載入...
PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and B Cell Responses
Tumor-specific neoantigens can be highly immunogenic, but their identification for each patient and the production of personalized cancer vaccines can be time-consuming and prohibitively expensive. In contrast, tumor-associated antigens are widely expressed and suitable as an off the shelf immunothe...
Na minha lista:
| 發表在: | Front Immunol |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7947615/ https://ncbi.nlm.nih.gov/pubmed/33717196 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.641703 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|